Ultra-rare pediatric rare diseases like PDC deficiency cannot support new clinical trials to address NDA deficiencies, Saol will tell the FDA. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
